Xpo1 inhibition increased cell death by 4.4-fold in MYC-driven HCC with high MYC expression levels while hardly affecting survival of cells with low MYC levels (Fig. 3e, Supplementary Fig. 8a, b). Here, XPO1 is linked to hepatocellular carcinoma.